Showing results (41-50 of 320) with videos related to
Sort By:
Pageof 32
Carcinogenesis|February 16, 2012
Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cellsGayathri Chadalapaka, Indira Jutooru, Stephen SafeThe Journal of Steroid Biochemistry and Molecular Biology|January 18, 2006
Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compoundsXiangrong Li, Shu Zhang, Stephen SafeThe Journal of Biological Chemistry|March 12, 2005
Induction of endoplasmic reticulum-induced stress genes in Panc-1 pancreatic cancer cells is dependent on Sp proteinsMaen Abdelrahim, Shengxi Liu, Stephen SafeJournal of Molecular Endocrinology|September 6, 2008
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathwaysStephen Safe, Kyounghyun Kim, Kyoungkim KimMolecular Cancer Therapeutics|November 5, 2016
Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription FactorsErik Hedrick, Xi Li, Stephen SafeBMC Cancer|December 18, 2015
Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factorsXi Li, Satya S Pathi, Stephen SafeMolecular Carcinogenesis|April 19, 2017
The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonistsErik Hedrick, Syng-Ook Lee, Stephen SafeChemico-Biological Interactions|November 13, 2004
Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7Adrian J Fretland, Stephen Safe, Oliver HankinsonCritical Reviews in Toxicology|June 30, 2020
Ah receptor ligands and their impacts on gut resilience: structure-activity effectsStephen Safe, Arul Jayaraman, Robert S ChapkinCurrent Opinion in Toxicology|May 2, 2017
The Aryl Hydrocarbon Receptor (AhR) as a Drug Target for Cancer ChemotherapyStephen Safe, Yating Cheng, Un-Ho JinPageof 32